Suche starten De menü ClientConnect
Suche starten
Ergebnisse
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20200200
    Veröffentlichungsdatum: 4 Juni 2020

    Projektträger – zwischengeschaltetes Finanzinstitut

    CREDIT AGRICOLE SA

    Ort

    Beschreibung

    The operation consists in a Multiple Beneficiary Intermediated Loan (MBIL) focusing on the healthcare and pharmaceutical sector in France. 20% will be dedicated to regions where access to medical experts is sub-optimal/underserved.

    Ziele

    The aim is to facilitate access to long-term finance for projects carried out by professionals and small and medium size enterprises (SMEs) in the healthcare and pharmaceutical sectors.

    Sektor(en)

    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 250 million

    Gesamtkosten (voraussichtlicher Betrag)

    not applicable

    Umweltaspekte

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.

    Auftragsvergabe

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.

    Projektstatus

    Unterzeichnet - 27/10/2020

    Haftungsausschluss

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Tags

    Frankreich Durchleitungsdarlehen